title: Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
authors.forename: James
authors.initials: J
authors.lastname: Li
authors.forename: Larry A
authors.initials: LA
authors.lastname: Nathanson
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Mills
authors.forename: Karin E
authors.initials: KE
authors.lastname: Netland
authors.forename: Richard
authors.initials: R
authors.lastname: Paula
authors.forename: Douglas
authors.initials: D
authors.lastname: Ragland
mesh_terms: D016265:Conflict of Interest; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator